Picard Medical turned gross profit positive with 85% revenue growth to $1.2M in Q1 2026 while reducing debt by $10.4M through cash repayment and stock settlement. The company raised $5.0M in May 2026 offering and restructured warrants to strengthen capital structure amid NYSE American listing compliance efforts.